ValiantLtd Valuation

Is 002643 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002643 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002643 (CN¥8.51) is trading below our estimate of fair value (CN¥12.1)

Significantly Below Fair Value: 002643 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002643?

Other financial metrics that can be useful for relative valuation.

002643 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.1x
Enterprise Value/EBITDA7.8x
PEG Ratio0.6x

Price to Earnings Ratio vs Peers

How does 002643's PE Ratio compare to its peers?

The above table shows the PE ratio for 002643 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.4x
301565 Sinolong New Materials
38.9xn/aCN¥7.4b
605008 Ningbo Changhong Polymer Scientific and Technical
70.2x50.4%CN¥7.6b
002010 Transfar Zhilian
17.1x20.4%CN¥8.4b
300641 Jiangsu Zhengdan Chemical Industry
35.2xn/aCN¥9.4b
002643 ValiantLtd
13.4x21.6%CN¥7.9b

Price-To-Earnings vs Peers: 002643 is good value based on its Price-To-Earnings Ratio (13.4x) compared to the peer average (40.4x).


Price to Earnings Ratio vs Industry

How does 002643's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a33.5%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a33.5%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 002643 is good value based on its Price-To-Earnings Ratio (13.4x) compared to the CN Chemicals industry average (27.7x).


Price to Earnings Ratio vs Fair Ratio

What is 002643's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002643 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.4x
Fair PE Ratio17.7x

Price-To-Earnings vs Fair Ratio: 002643 is good value based on its Price-To-Earnings Ratio (13.4x) compared to the estimated Fair Price-To-Earnings Ratio (17.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 002643 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥8.51
CN¥13.75
+61.6%
21.6%CN¥18.00CN¥10.50n/a4
Aug ’25CN¥9.44
CN¥18.25
+93.3%
13.6%CN¥22.00CN¥15.00n/a4
Jul ’25CN¥9.94
CN¥18.25
+83.6%
13.6%CN¥22.00CN¥15.00n/a4
Jun ’25CN¥11.61
CN¥18.25
+57.2%
13.6%CN¥22.00CN¥15.00n/a4
May ’25CN¥11.51
CN¥18.31
+59.1%
12.2%CN¥22.00CN¥15.00n/a5
Apr ’25CN¥13.86
CN¥22.34
+61.2%
15.8%CN¥28.50CN¥18.00n/a6
Mar ’25CN¥15.19
CN¥22.34
+47.1%
15.8%CN¥28.50CN¥18.00n/a6
Feb ’25CN¥12.94
CN¥22.34
+72.6%
15.8%CN¥28.50CN¥18.00n/a6
Jan ’25CN¥16.59
CN¥23.54
+41.9%
12.9%CN¥28.50CN¥18.54n/a6
Dec ’24CN¥16.14
CN¥23.54
+45.8%
12.9%CN¥28.50CN¥18.54n/a6
Nov ’24CN¥16.97
CN¥23.26
+37.1%
12.7%CN¥28.50CN¥18.54n/a6
Oct ’24CN¥17.26
CN¥23.26
+34.8%
12.7%CN¥28.50CN¥18.54n/a6
Sep ’24CN¥17.50
CN¥23.26
+32.9%
12.7%CN¥28.50CN¥18.54CN¥8.506
Aug ’24CN¥18.09
CN¥22.41
+23.9%
9.7%CN¥25.00CN¥18.54CN¥9.445
Jul ’24CN¥17.41
CN¥22.41
+28.7%
9.7%CN¥25.00CN¥18.54CN¥9.945
Jun ’24CN¥16.15
CN¥22.86
+41.5%
6.2%CN¥25.00CN¥20.77CN¥11.615
May ’24CN¥18.31
CN¥22.86
+24.8%
6.2%CN¥25.00CN¥20.77CN¥11.515
Apr ’24CN¥17.23
CN¥22.69
+31.7%
9.5%CN¥25.60CN¥20.47CN¥13.863
Mar ’24CN¥17.86
CN¥22.69
+27.0%
9.5%CN¥25.60CN¥20.47CN¥15.193
Feb ’24CN¥18.82
CN¥22.69
+20.6%
9.5%CN¥25.60CN¥20.47CN¥12.943
Jan ’24CN¥14.66
CN¥22.69
+54.8%
9.5%CN¥25.60CN¥20.47CN¥16.593
Dec ’23CN¥16.82
CN¥22.69
+34.9%
9.5%CN¥25.60CN¥20.47CN¥16.143
Nov ’23CN¥14.19
CN¥25.08
+76.8%
9.3%CN¥27.65CN¥22.00CN¥16.973
Oct ’23CN¥14.58
CN¥27.68
+89.9%
2.1%CN¥28.40CN¥27.00CN¥17.263
Sep ’23CN¥17.79
CN¥27.68
+55.6%
2.1%CN¥28.40CN¥27.00CN¥17.503

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies